Global Incretin Based Drugs Market (2023 Edition): Market Insights and Forecast (2019-2029)

Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country

Published	Pages	Publisher	Report code
Dec 2023	230	Azoth Analytics	ASDR-640930

Published: Dec 2023 - Pages : 230 - Publisher : Azoth Analytics - Report code : ASDR-640930

Eli Lilly and Company
Boehringer Ingelheim
Novo Nordisk
AstraZeneca PLC
Merck & Co. Inc. Pfizer
Novartis AG
Takeda Pharmaceuticals
Bristol Myers Squibb
Structure Therapeutics.

Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Market Insights and Forecast (2020-2030)

This report can be of interest as well:

Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Market Insights and Forecast (2020-2030)

Published: February, 2024 | Report code: ASDR-654804